Maze Therapeutics, Inc. Common Stock MAZE
$28.38
+26.75%
at last close
Financials (TTM)
- Revenue
- $20.00 million
- Net Income
- $-133,590,000
- Net Margin
- -667.95%
- Return on Equity
- -29.48%
- Debt-to-Equity
- 0.09
- P/E Ratio
- —
- Price / Book
- 2.74
- Price / Sales
- 62.19
Over the trailing twelve months, Maze Therapeutics, Inc. Common Stock generated revenue of $20.00 million and net income of $-133,590,000, a net margin of -667.95%.
At the last closing price of $28.38, MAZE trades at 62.19 times sales, with a market capitalization of $1.24 billion.
Key Stats
- Last Close
- $28.38
- Market Cap
- $1.24 billion
- 52-Week Range
- $12.81 – $53.65
- Average Volume
- 581K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.